BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9552382)

  • 1. A temporal and biochemical link between growth factor-activated MAP kinases, cyclin D1 induction and cell cycle entry.
    Lavoie JN; Rivard N; L'Allemain G; Pouysségur J
    Prog Cell Cycle Res; 1996; 2():49-58. PubMed ID: 9552382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1).
    Cheng M; Sexl V; Sherr CJ; Roussel MF
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1091-6. PubMed ID: 9448290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anchorage-dependent signal distinct from p42/44 MAP kinase activation is required for cell cycle progression.
    Le Gall M; Grall D; Chambard JC; Pouysségur J; Van Obberghen-Schilling E
    Oncogene; 1998 Sep; 17(10):1271-7. PubMed ID: 9771970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts.
    Takuwa N; Takuwa Y
    Mol Cell Biol; 1997 Sep; 17(9):5348-58. PubMed ID: 9271412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion control of cyclin D1 and p27Kip1 levels is deregulated in melanoma cells through BRAF-MEK-ERK signaling.
    Bhatt KV; Spofford LS; Aram G; McMullen M; Pumiglia K; Aplin AE
    Oncogene; 2005 May; 24(21):3459-71. PubMed ID: 15735667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and modulation of p42/p44 MAPKs and cell cycle regulatory proteins in rat pancreas regeneration.
    Morisset J; Aliaga JC; Calvo EL; Bourassa J; Rivard N
    Am J Physiol; 1999 Nov; 277(5):G953-9. PubMed ID: 10564100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAP kinase cascade is required for p27 downregulation and S phase entry in fibroblasts and epithelial cells.
    Rivard N; Boucher MJ; Asselin C; L'Allemain G
    Am J Physiol; 1999 Oct; 277(4):C652-64. PubMed ID: 10516095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein.
    Zhu X; Ohtsubo M; Böhmer RM; Roberts JM; Assoian RK
    J Cell Biol; 1996 Apr; 133(2):391-403. PubMed ID: 8609171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.
    Lenferink AE; Busse D; Flanagan WM; Yakes FM; Arteaga CL
    Cancer Res; 2001 Sep; 61(17):6583-91. PubMed ID: 11522658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive overexpression of cyclin D1 in human breast epithelial cells does not prevent G1 arrest induced by deprivation of epidermal growth factor.
    Chou JL; Fan Z; DeBlasio T; Koff A; Rosen N; Mendelsohn J
    Breast Cancer Res Treat; 1999 Jun; 55(3):267-83. PubMed ID: 10517171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells.
    Fiddes RJ; Janes PW; Sivertsen SP; Sutherland RL; Musgrove EA; Daly RJ
    Oncogene; 1998 May; 16(21):2803-13. PubMed ID: 9652748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redistribution of the CDK inhibitor p27 between different cyclin.CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation.
    Poon RY; Toyoshima H; Hunter T
    Mol Biol Cell; 1995 Sep; 6(9):1197-213. PubMed ID: 8534916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
    Gysin S; Lee SH; Dean NM; McMahon M
    Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic.
    Tombes RM; Auer KL; Mikkelsen R; Valerie K; Wymann MP; Marshall CJ; McMahon M; Dent P
    Biochem J; 1998 Mar; 330 ( Pt 3)(Pt 3):1451-60. PubMed ID: 9494119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.